Thirty-one monoclonal antibodies, specific for either the nucleoprotein (N) or the non-structural protein (NS; nucleocapsid-associated protein) of the nucleocapsid of the ERA strain of rabies virus, were used to investigate the topography of antigenic sites on the nucleocapsid complex. Based on the results of a competitive enzyme immunoabsorbent assay using these antibodies, five spatially distinct antigenic sites were defined: three on the N protein (groups N I, NII and N III) and two on the NS protein (groups NS I and NS II). Antigenic variations among various street and laboratory strains of rabies virus were analysed by indirect immunofluorescence assay with the monoclonal antibodies specific for the nucleocapsid. Some correlation between the natural nucleocapsid variation and the antigenic topographical map was observed. 0000-6549 © 1985 SGM Downloaded from www.microbiologyresearch.org by IP: 54.191.40.80 On: Sat, 09 Sep 2017 02:31:15 2126 M. LAFON AND T. J. WIKTOR METHODS Cell cultures and viruses. The ERA strain of rabies virus (obtained from
INTRODUCTION
Rabies virus is an enveloped rhabdovirus with a single, non-segmented negative-strand RNA. The virus contains multiple copies of five structural proteins : the virion transcriptase (L), glycoprotein (G), nucleoprotein (N), the nucleocapsid-associated protein (NS) and matrix (M) protein. The L, N and NS proteins are non-covalently bound to the virion RNA and the resulting nucleocapsid (NC) complex forms a helically coiled structure within the virion. The NC is surrounded by a lipoprotein envelope consisting of M protein and the surface projections" of G proteins extend to the exterior of the virus. The N protein is a major protein of the NC and constitutes approximately 309/o of the total viral protein (Sokol et al., 1971) . The NS protein, on the other hand, is a minor component of the virus (10 ~o), but represents a significantly greater proportion of the virus-specific protein synthesized in virus-infected cells; hence, the original designation of 'non-structural' for NS protein (Zaides et al., 1979) .
Antibodies prepared against whole rabies virions or against rabies virus NC are routinely used in an immunofluorescence staining procedure for the detection of viral inclusions (Negri bodies) in rabies-infected brain cells (Dean & Abelseth, 1973) . This procedure has enabled the rapid diagnosis of rabies virus infection. Monoclonal antibodies have been used to distinguish between rabies and rabies-related viruses at the N protein level, but also have revealed extensive antigenic variation in both the G and N proteins of a number of laboratory and street rabies virus strains (Flamand et al., 1980a, b; . The antigenic structure of the rabies virus G protein has been analysed using virusneutralizing monoclonal antibodies and laboratory-selected mutant viruses. Three functionally independent antigenic sites were delineated on the CVS-11 rabies virus G molecule; these sites were identical to three of five sites defined on the G protein of the ERA strain Wiktor et al., 1983) .
In this study, we analysed the antigenic structure of the rabies virus NC complex using a competitive enzyme immunoabsorbent binding assay (CEIA) with a panel of monoclonal antibodies specific for the N and the NS proteins. Competitive enzyme immunoassay. Monoclonal antibodies were dialysed against 0.15 M-NaC1, and labelled with horseradish peroxidase according to the technique of Avrameas & Ternynck (1971) , using 10 mg peroxidase (LKB 2215 410) dissolved in 0.2 ml 1 ~ glutaraldehyde solution in 0.1 M-phosphate buffer pH 6.8, incubated at room temperature for 18 h, and passed through a Sephadex G-25 column. Brown-coloured fractions were collected and added to 5 mg of monoclonal antibody in carbonate-bicarbonate buffer pH 9.5. The mixture was maintained for 24 h at 4 °C and dialysed extensively against PBS. Dynatech (Greiner) Immunolon micro-EIA plates were coated with whole u.v.-inactivated ERA rabies virus (400 ng/100 ~tl/well) in carbonate-bicarbonate buffer pH 9.6 overnight, then blocked with PBST and 0.3 ~ BSA for 30 min at room temperature. Dilutions of unlabelled ascitic fluids in PBST plus 0.3~ BSA (PBST-BSA) were added, followed immediately by a constant amount of peroxidase-labelled purified ascitic fluid in 100 i11 PBST-BSA. The plates were first agitated, then incubated at 37 °C in a moist chamber for 90 rain and finally washed five times with PBST. The bound peroxidase-labelled ascitic fluid was detected by adding 100 I11 of o-phenylenediamine substrate per well, and the reaction was stopped 30 rain later by the addition of 25 ~tl of 3 M-H2SO4 per well. Optical density (OD) at 492 nm was determined with a Titertek Multiskan photometer. Peroxidase-labelled ascitic fluid was used at a less than saturating dilution, predetermined by titration in the presence of 100 lal of PBST-BSA. This dilution corresponded to an OD of nearly 1. Results were expressed as percentage of competition: [(OD~x -ODt~0/ODmj x 100, where OD~x is OD in the absence of competitor, and ODt~t is OD in the presence of competitor. Anti-glycoprotein monoclonal antibody ascitic fluid (PVE-3) was used as a negative control.
RESULTS

Characterization of anti-N protein and anti-NS protein monoclonal antibodies
The 31 monoclonal antibodies used in this study stained intracytoplasmic inclusions of ERA rabies virus-infected, acetone-fixed BHK-21 cells and were considered to be specific for the NC antigen complex (Schneider et al., 1973; Wiktor & Koprowski, 1978) . To test the specificity of the monoclonal antibodies for either the NS protein or the N protein, which constitute the NC antigen, the two proteins were separated by SDS-PAGE and used as immunosorbents in EIA.
Threefold dilutions of ascitic fluids were tested for their reactivity with SDS-purified antigens and also with CsCl-purified NC and whole virions ( Fig. 1 ). All of the monoclonal antibodies were reactive with whole virus. Only two monoclonal antibodies, 701-9 and 721-2, did not bind either the CsCl-purified NC or the SDS-purified N protein, and only these two antibodies detected the SDS-purified NS protein ( Fig. 1 a, results for monoclonal antibody 701-9 only). Because the NS epitopes detected by the two antibodies were resistant to denaturation by SDS, they are designated sequential epitopes. Conversely, epitopes sensitive to SDS denaturation are designated conformational epitopes. Among the 29 monoclonal antibodies specific for the N protein, most recognized conformational epitopes ( Fig. 1 b, results for monoclonal antibody 120-2 only), but five of them (377-7, 805-3, 816-1, 239-1 and 389-1) also recognized sequential epitopes on the N protein since they bound to the SDS-purified N protein. Fig. 1 (c) shows results with monoclonal antibody 377-7 only. 
Antibody dilution
Antigenic analysis of N and NS proteins by competitive EIA
The topographical relationship of antigenic regions of the N and NS proteins was analysed in competitive EIA. Each of the 31 monoclonal antibodies was tested for its ability to compete with peroxidase-labelled monoclonal antibodies for binding to whole purified rabies virus. Fig. 2 shows an example of the binding inhibition with the peroxidase-labelled monoclonal antibodies 805-3, which competed with itself and with 104-4 but not with antibody 801-1,701-5 or antiglycoprotein monoclonal antibody PVE-3. Competition higher than 25 ~ was taken as positive, based on the maximal competition between PVE-3 and anti-N antibody for binding to whole virus. The amount of monoclonal antibody necessary to inhibit the binding of peroxidaselabelled monoclonal antibody by 50~o was calculated for each case. Table 1 shows results for four monoclonal antibodies representing functionally distinct antigenic sites on the N protein. After analysis using a Van der Giessen algorithm (Van der Giessen, 1970), five different patterns of competition emerged as shown in Fig. 3 . The binding of the two NS-specific monoclonal antibodies was inhibited only by the homologous antibodies, delineating antigenic sites NS I and NS II of the ERA virus NS protein. Twenty-nine anti-N monoclonal antibodies delineated three functionally distinct sites : a single antibody, 377-7, defined site N I, whereas sites NII and N III were defined, respectively, by eight and 20 antibodies. In competition assay of these anti-N protein sites II and III antibodies, cross-competition was restricted to members of the same group. As shown previously in competition analyses using anti-G protein monoclonal antibodies , the competition was not always reciprocal. This was the case for two anti-N protein monoclonal antibodies 111-1 and PVB-1. All antibodies of the site III group blocked binding of the labelled antibodies 111-1 and PVB-1 ; however, antibodies 111-1 and PVB-1 were not able to compete with the binding of labelled site III antibodies.
Antigenic variation in N and NS protein determinants
We have previously shown ) that antigenic differences among strains of rabies and rabies-related viruses can be detected using a smaller panel of monoclonal antibodies specific for N antigen of the virus. Although laboratory strains of rabies virus (CVS, PM, LEP, ERA and Kelev) are recognized by all rabies virus-specific monoclonal antibodies of our panel (Flamand et al., 1980a; Schneider, 1982; T. J. Wiktor, unpublished) , only the HEP and several street strains of virus isolated from different animal species and geographical locations could be distinguished on the basis of their lack of reactivity with one or several antibodies of the panel. One monoclonal antibody (422-5) was specific for rabies-related viruses. Our previous data (Wiktor et al., 1984; Koprowski et al., 1985 ; Rupprecht & Wiktor, 1985) were re-analysed in light of the newly defined specificities of two anti-NS protein monoclonal antibodies and delineation of the three antigenic sites of ERA virus N protein by the anti-N protein monoclonal antibodies. 
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The reactivity patterns of the numerous strains of virus analysed can be divided into 10 groups, labelled A to J (Fig. 4) . Groups A, B and C represent the Mokola, Lagos bat and Duvenhage strains of rabies-related viruses, respectively. None of these was recognized by two antibodies specific for the NS antigen or by anti-N protein monoclonal antibody 377-7 defining site I. In addition, all but one of the eight anti-N protein antibodies defining site II failed to recognize the rabies-related strains. Antibody 808-2 recognized all three strains. Further distinctions between rabies-related virus strains were made, because antibody 803-6 recognized the Lagos bat and Duvenhage strains, and antibody 801-1 recognized Lagos bat virus only.
Out of 20 site III anti-N protein monoclonal antibodies, nine recognized all three strains of rabies-related viruses, three additional monoclonal antibodies (237-3, 703-8 and 239-1) recognized Mokola virus only, and antibody 222-9 recognized Mokola and Lagos bat viruses. Monoclonal antibody PVB-1 recognized Duvenhage virus but not Mokola or Lagos bat viruses.
Strains of rabies virus belonging to group D (Flury HEP) and group E (five strains isolated from bats in the eastern United States and Canada) could be differentiated only by the two anti-NS protein antibodies. These strains otherwise showed very little homology with the rabies virus ERA strain since they were not recognized by 11 out of 20 anti-N protein antibodies of site III. Fifty-six out of 77 strains examined are located in four groups (F, G, H, I). None of these was reactive with the anti-NS protein antibodies defining site I. Some were non-reactive with one to three epitopes recognized by anti-N protein antibodies specific for sites I and III on N protein.
No differences were observed in the reactivity with anti-N antibodies of site II. Finally, group J included six strains isolated from foxes in western Europe; none of these strains was reactive with antibodies 590-2 and 364-1 of site III on N protein, and the reactivity with anti-N protein monoclonal antibody 103-7 was variable. This pattern of reactivity was previously observed in 53 strains isolated in Europe from different animal species (Sureau et al., 1983; Blancou et al., 1982; Schneider, 1982) .
DISCUSSION
In this study, 31 monoclonal antibodies recognizing the ERA rabies virus NC complex were used in the topographical analysis of the antigenic structure of this complex. The specificity of these antibodies for N and NS proteins, which form the NC complex, was defined by their binding in EIA tests to two kinds of immunoabsorbents: the SDS-purified antigen obtained from purified virions, and the CsCl-purified NC extracted from virus-infected cells. We had expected CsCl-purified NC to contain N, NS and L proteins, but SDS-PAGE analysis of our CsCl-purified preparation revealed no NS or L protein. This finding was confirmed by the absence of reactivity of anti-NS polyclonal serum with CsCl-purified NC in EIA. Thus, the CsCl-purified NC preparation contained chiefly N protein, or the NS protein was present in amounts insufficient for detection by our assay, or the cell-and virus-associated NS proteins are antigenically distinct.
All monoclonal antibodies that reacted with CsCl-purified NC antigen and not with SDSpurified NS or N antigens were considered to be anti-N antibodies, recognizing conformational epitopes, in contrast to antibodies reacting with SDS-purified N antigen which recognize sequential epitopes. The specificity of two antibodies to sequential epitopes of the NS protein was deduced from the absence of binding to CsCl-purified NC and from binding to SDSpurified NS antigens.
Competitive enzyme immunoassay data revealed five different patterns of inhibition, suggesting the presence of five topographically discrete sites: two were located on the NS protein and three on the N protein. Analysis of monoclonal antibody specificity for these two major proteins of the NC complex, using purified denatured antigens and non-denatured antigens as EIA immunoabsorbents, suggest (i) the topographical independence of the N and NS proteins, i.e. several antibodies failed to react with either of these proteins, and antibody recognition of sites I and II of the NS protein did not overlap with that of the three antigenic sites of the N protein, and (ii) the N protein has both conformational and sequential epitopes. Sequential epitopes are present only at sites I and III.
The lack of reciprocity in binding, as in the case of anti-N protein monoctonal antibodies 111-1 and PVB-1, might rest in the lower avidity of both antibodies to the antigen or to a particular spatial arrangement of their corresponding epitopes. However, at least for antibody PVB-1, low avidity does not seem to be a factor because competition was still low, even with an increased amount of competitor antibody (results not shown).
The topographical distribution of antigenic sites on the N and NS proteins of rabies virus was confirmed by data obtained from analysis of laboratory and street rabies and rabies-related viruses. Whereas all laboratory strains of virus (with the exception of Flury HEP virus) were recognized in previous studies by all rabies-specific monoclonal antibodies , differences were observed in the reactivity pattern of rabies-related viruses and of most of the field rabies virus isolates. Rabies-related viruses do not express the determinants present on the ERA rabies virus NS protein and lack more than half of the determinants recognized by the anti-N protein monoclonal antibodies. In all field rabies virus isolates from the United States and Canada tested in this study, the site I determinants of the NS protein and several site III determinants of the N protein were not detected. Remarkably, site II, which is composed only of conformational epitopes of the N protein, is conserved in all rabies virus field isolates. In contrast, sequential epitopes on site III that are recognized by monoclonal antibody 239-1 are always present in both rabies and rabies-related viruses. This is the first description of monoclonal antibodies with specificity for the NS protein of rabies virus. These antibodies will be useful for purification of the NS protein from virions and from rabies virus-infected cells, and for studying the functional role of NS in virus replication. Parts of this work were supported by the National Institutes of Health grant AI-09706.
